HKD 55.1
(-1.08%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 11.87 Billion CNY | 11.45% |
2022 | 10.65 Billion CNY | 76.43% |
2021 | 6.03 Billion CNY | 78.13% |
2020 | 3.38 Billion CNY | 44.79% |
2019 | 2.34 Billion CNY | -9.43% |
2018 | 2.58 Billion CNY | 76.96% |
2017 | 1.46 Billion CNY | 13.7% |
2016 | 1.28 Billion CNY | 66.47% |
2015 | 771.67 Million CNY | -10.47% |
2014 | 861.96 Million CNY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q3 | 2.81 Billion CNY | 1.58% |
2024 Q1 | 2.3 Billion CNY | 11.86% |
2024 Q2 | 2.76 Billion CNY | 19.86% |
2023 Q1 | 2.61 Billion CNY | -15.49% |
2023 Q3 | 3.39 Billion CNY | -10.59% |
2023 Q4 | 2.06 Billion CNY | -39.18% |
2023 FY | 11.87 Billion CNY | 11.45% |
2023 Q2 | 3.79 Billion CNY | 45.18% |
2022 Q3 | 2.29 Billion CNY | -35.37% |
2022 FY | 10.65 Billion CNY | 76.43% |
2022 Q4 | 3.09 Billion CNY | 34.92% |
2022 Q2 | 3.54 Billion CNY | 77.03% |
2022 Q1 | 2 Billion CNY | 15.53% |
2021 Q3 | 1.11 Billion CNY | -25.1% |
2021 FY | 6.03 Billion CNY | 78.13% |
2021 Q4 | 1.73 Billion CNY | 55.58% |
2021 Q2 | 1.48 Billion CNY | -12.27% |
2021 Q1 | 1.69 Billion CNY | 154.96% |
2020 Q4 | 665.79 Million CNY | -15.98% |
2020 Q3 | 792.41 Million CNY | -47.56% |
2020 Q1 | 420.24 Million CNY | 121.72% |
2020 Q2 | 1.51 Billion CNY | 259.56% |
2020 FY | 3.38 Billion CNY | 44.79% |
2019 Q3 | 864.3 Million CNY | 10.7% |
2019 FY | 2.34 Billion CNY | -9.43% |
2019 Q4 | 189.54 Million CNY | -78.07% |
2019 Q2 | 780.8 Million CNY | 54.23% |
2019 Q1 | 506.27 Million CNY | 21.75% |
2018 Q4 | 415.83 Million CNY | -44.81% |
2018 FY | 2.58 Billion CNY | 76.96% |
2018 Q2 | 1.05 Billion CNY | 187.44% |
2018 Q1 | 365.31 Million CNY | 48.29% |
2018 Q3 | 753.5 Million CNY | -28.24% |
2017 Q2 | 485.95 Million CNY | 14.31% |
2017 Q1 | 425.12 Million CNY | 0.0% |
2017 FY | 1.46 Billion CNY | 13.7% |
2017 Q4 | 246.35 Million CNY | -30.21% |
2017 Q3 | 353.01 Million CNY | -27.36% |
2016 FY | 1.28 Billion CNY | 66.47% |
2015 FY | 771.67 Million CNY | -10.47% |
2014 FY | 861.96 Million CNY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Life Healthcare Group Limited | 17.63 Million HKD | -67226.108% |
China Biotech Services Holdings Limited | -127.67 Million HKD | 9398.907% |